Innate Pharma SA (IPHYF) Revenue
Innate Pharma SA Revenue
Innate Pharma SA had a revenue of 3.12M in the quarter ending Jun 30, 2026, with 250.27%. This bring the company's revenue in the last twelve months to 1.04M, Decreased 62.61%. In the fiscal year ending Dec 31, 2025, Innate Pharma SA had annual revenue of 2.79M with -77.92% growth.
- Revenue (ttm)
- 1.04M
- Revenue Growth
- -24.21%
- P/S Ratio
- 56.41
- Revenue/Employee
- $23,225
- Employees
- 120
- Market Cap
- $157.21M
Revenue Chart
Innate Pharma SA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.79M | -9.84M | -77.92% |
| Dec 31, 2024 | 12.62M | -39.28M | -75.68% |
| Dec 31, 2023 | 51.90M | 2.26M | 4.56% |
| Dec 31, 2022 | 49.64M | 37.53M | 309.83% |
| Dec 31, 2021 | 12.11M | -57.66M | -82.64% |
| Dec 31, 2020 | 69.77M | 800.00K | 1.16% |
| Dec 31, 2019 | 68.97M | -10.92M | -13.67% |
| Dec 31, 2018 | 79.89M | 47.26M | 144.83% |
| Dec 31, 2017 | 32.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.